What Have We Lost in the Wake of the Rosiglitazone Controversy?

Endocrine Practice

Volumn 15, Issue 3, 2009, Pages 276-277

  Bhadada, Sanjay Kumar ^a   Rao, D Sudhaker ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE; GENE MUTATION; GENETIC DISORDER; HRPT2 GENE; HUMAN; HYPERPARATHYROIDISM; HYPERPARATHYROIDISM JAW TUMOR SYNDROME; JAW TUMOR; LETTER; NEEDLE BIOPSY; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; VITAMIN D DEFICIENCY; ALBRIGHT SYNDROME; DIFFERENTIAL DIAGNOSIS; GENETICS; MUTATION; NOTE; OSSIFYING FIBROMA; OSTEOMALACIA; SYNDROME;

CDC73 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

DIAGNOSIS, DIFFERENTIAL; FIBROMA, OSSIFYING; HUMANS; HYPERPARATHYROIDISM; JAW NEOPLASMS; MUTATION; OSTEITIS FIBROSA CYSTICA; OSTEOMALACIA; SYNDROME; TUMOR SUPPRESSOR PROTEINS;

EID: 67651109150     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Carlson AL, Smith CL.Primary hyperparathyroidism and jaw tumor syndrome: a novel mutation of the HRPT2 gene. Endocr Pract. 2008;14:743-746.
2. Haven CJ, Wong FK, van Dam EW, et al.A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab. 2000;85:1449-1454.
3. Mithal A, Bandeira F, Meng X, et al.Clinical presentation of primary hyperparathyroidism: India, Brazil, and China. In: Bilezikian JP, Levine MA, Marcus R, eds. The Parathyroids: Basic and Clinical Concepts. San Diego, CA: Academic Press, 2001: 375-380.
4. Rao DS, Agarwal G, Talpos GB, et al.Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J Bone Miner Res. 2002;17(Suppl 2): N75-N80.
5. Rao DS, Honasage M, Divine GW, et al.Effect of vitamin D nutritional parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab. 2000;85:1054-1058.
6. Kulak CA, Bandeira C, Voss D, et al.Marked improvement in bone mass after parathyroidectomy in osteitis fibrosa cystica. J Clin Endocrinol Metab. 1998;83:732-735.
7. Carpten JD, Robbins CM, Villablanca A, et al.HRPT2, encoding parafibromin, is mutated in hyperparathyroidismjaw tumor syndrome. Nat Genet. 2002;32:676-680.